Long term follow-up of skeletal dysplasia in thalassaemia major

Journal of Pediatric Endocrinology and Metabolism

Volumn 11, Issue SUPPL. 3, 1998, Pages 817-825

  Naselli, A ^a   Vignolo, M ^a   Di Battista, E ^a   Garzia, P ^a   Forni, G L ^a   Traverso, T ^a   Aicardi, G ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Deferoxamine toxicity; Growth failure; Limb and spinal deformities; Skeletal dysplasia; Spondylo metaphyseal changes; Thalassaemia major

Indexed keywords

DEFEROXAMINE;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; BONE DYSPLASIA; BONE RADIOGRAPHY; CHELATION THERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; FEMALE; FOLLOW UP; GROWTH DISORDER; HUMAN; LIMB DEFORMITY; MALE; METAPHYSIS; SPINE MALFORMATION; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; BODY HEIGHT; BONE DISEASES, DEVELOPMENTAL; DEFEROXAMINE; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; GROWTH PLATE; HUMAN GROWTH HORMONE; HUMANS; IRON CHELATING AGENTS; KNEE; MALE; SPINAL DISEASES; WRIST;

EID: 0032431486     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Brill PW, Winchester P, Giardina PJ, Cunningham-Rundles S. Deferoxamine-induced bone dysplasia in patients with thalassemia major. AIR 1991; 156: 561-565.
2. De Virgiliis S, Congia M, Frau F, Argiolu F, Diana G, Cucca F, Varsi A, Sanna G, Podda G, Fodde M, Pirastu GF, Cao A. Deferoxamine-induced growth retardation in patients with thalassemia major. J Pediatr 1988; 113: 661-669.
3. Harris JN, McGee A, Calderbank M, Reilly BJ, Bailey J, Freedman M, Koren G, Olivieri NF. Deferoxamine-induced growth retardation in patients with thalassemia major. Blood 1989; 74 (suppl 1): 220a (abstract).
4. Orzincolo C, Castaldi G, De Sanctis V, Scutellari PN, Ciaccio C, Vullo C. Lesioni scheletriche similrachitiche e/o scorbutiche nella β-talassemia major. Radiol Med 1990; 80: 823-829.
5. Naselli A, Asquasciati G, Cerbello G, Coroli P, Di Battista E, Taddei L, Vignolo M. A case of severe spondylo-metaphyseal dysplasia and thalassemia major early chelated. "Congrès International sur les Maladies Genetique de l'Hemoglobine: Thalassèmies, Drèpanocytose et Autres Hèmoglobinopathies". Nice-Acropolis November 1991; Abstracts Book: 188.
6. Naselli A, Vignolo M, Di Battista E, Mattei R, Aicardi G. Spondylometaphyseal abnormalities and severe short stature in a deferoxamine-treated homozygous beta-thalassemia patient. Acta Med Auxol 1995; 27: 125-132.
7. Olivieri NF, Koren G, Harris J, Khattak S, Freedman MH, Templeton DM, Bailey JD, Reilly BJ. Growth failure and bony changes induced by deferoxamine. Am J Pediatr Hematol Oncol 1992; 14: 48-56.
8. Orzincolo C, Scutellari PN, Castaldi G. Growth plate injury of the long bones in treated β-thalassemia. Skeletal Radiol 1992; 21: 39-44.
9. Williams BA, Morris LL, Toogood IRG, Penfold JL, Foster BK. Limb deformity and metaphyseal abnormalities in thalassemia major. Am J Pediatr Hematol Oncol 1992; 14:197-201.
10. Borenstein ZCF, Hyman CB, Rimoin DL, Chapman CL, Lachman R. Quiz. Case report 744. Diagnosis: Deferoxamine-induced skeletal dysplasia. Skeletal Radiol 1993; 21: 534-537.
11. Hartkamp MJ, Babyn PS, Olivieri F. Spinal deformities in deferoxamine-treated homozygous beta-thalassemia major patients. Pediatr Radiol 1993; 23: 525-528.
12. Melevendi C, Form GL, Jappelli S, Di Battista E, Naselli A. Bone dysplasia and short stature in thalassemia major. 5th International Conference on Thalassaemias and the Haemoglobinopathies. Nicosia-Cyprus, 29 March-3 April 1993. Panos I Ed. 1993; Abstract Book: 309.
13. Orzincolo C, Castaldi G, Scutellari PN. Platyspondyly in treated beta-thalassemia. Eur J Radiol 1994; 18: 129-133.
14. Levin TL, Sheth S, Berdon WE, Ruzal-Shapiro C, Piomelli S. Deferoxamine-induced platyspondyly in hypertransfused thalassemic patients. Pediatr Radiol 1995; 25: S122-S124.
15. De Sanctis V, Pinamonti A, Di Palma A, Sprocati M, Atti G, Gamberini MR, Vullo C. Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine. Eur J Pediatr 1996; 155: 368-372.